190 related articles for article (PubMed ID: 37457950)
1. Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies.
Wang J; Wang M; Zhao A; Zhou H; Mu M; Liu X; Niu T
Front Cell Infect Microbiol; 2023; 13():1167638. PubMed ID: 37457950
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections.
Tang Y; Cheng Q; Yang Q; Liu J; Zhang D; Cao W; Liu Q; Zhou T; Zeng H; Zhou L; Wang Q; Wei H; Li X
Infection; 2018 Aug; 46(4):513-521. PubMed ID: 29767394
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases.
Jian X; Du S; Zhou X; Xu Z; Wang K; Dong X; Hu J; Wang H
Front Cell Infect Microbiol; 2022; 12():969117. PubMed ID: 36683699
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
Gill EL; Gill CM; McEvoy C
Ann Hematol; 2024 May; 103(5):1745-1752. PubMed ID: 38453704
[TBL] [Abstract][Full Text] [Related]
8. [Single Center Analysis of Bloodstream Infection Clinical Characteristics and Prognosis in Patients with Hematological Malignancies in the Tropics].
Cheng LC; Yang T; Kuang HH; Yu S; Guan LX; Gu ZY; Xu YY; Zheng WS; Wang L; Hu YL; Gao XN; Wang QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):265-271. PubMed ID: 33554832
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012-2019.
Li M; Du M; Li H; Liu D; Liu Y
Infect Med (Beijing); 2022 Mar; 1(1):23-30. PubMed ID: 38074981
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.
Ammann RA; Laws HJ; Schrey D; Ehlert K; Moser O; Dilloo D; Bode U; Wawer A; Schrauder A; Cario G; Laengler A; Graf N; Furtwängler R; Simon A
Eur J Pediatr; 2015 May; 174(5):675-86. PubMed ID: 25804192
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Trecarichi EM; Pagano L; Martino B; Candoni A; Di Blasi R; Nadali G; Fianchi L; Delia M; Sica S; Perriello V; Busca A; Aversa F; Fanci R; Melillo L; Lessi F; Del Principe MI; Cattaneo C; Tumbarello M;
Am J Hematol; 2016 Nov; 91(11):1076-1081. PubMed ID: 27428072
[TBL] [Abstract][Full Text] [Related]
12. Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.
Tumbarello M; Trecarichi EM; Caira M; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Spadea A; Busca A; Vianelli N; Spanu T; Pagano L;
PLoS One; 2012; 7(12):e51612. PubMed ID: 23272123
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream infection clusters for critically ill patients: analysis of two-center retrospective cohorts.
Wang L; Zhang L; Huang X; Xu H; Huang W
BMC Infect Dis; 2024 Mar; 24(1):306. PubMed ID: 38481153
[TBL] [Abstract][Full Text] [Related]
15. A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy.
Chen S; Lin K; Li Q; Luo X; Xiao M; Chen M; Zhu H; Chen Y; Wu X; Zeng Y; Zhang Y; Ally IH; Xu J; Ren J; Chen Z; Hu J; Yang T
J Cancer; 2021; 12(18):5494-5505. PubMed ID: 34405012
[No Abstract] [Full Text] [Related]
16. Breakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections.
Papadimitriou-Olivgeris M; Kolonitsiou F; Solomou A; Karamouzos V; Anastassiou ED; Christofidou M; Spiliopoulou I; Fligou F; Marangos M
J Med Microbiol; 2019 Oct; 68(10):1544-1551. PubMed ID: 31436523
[No Abstract] [Full Text] [Related]
17. Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study.
Wang S; Song Y; Shi N; Yin D; Kang J; Cai W; Duan J
Infect Drug Resist; 2023; 16():4471-4487. PubMed ID: 37449245
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study.
Cai L; Chen H; Wei Y; Guo X; Zheng H; Jiang X; Zhang Y; Yu G; Dai M; Ye J; Zhou H; Xu D; Huang F; Fan Z; Xu N; Shi P; Xuan L; Feng R; Liu X; Sun J; Liu Q; Wei X
BMJ Open; 2023 Dec; 13(12):e078510. PubMed ID: 38159939
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
[No Abstract] [Full Text] [Related]
20. Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies - The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study.
Tang Y; Xu C; Xiao H; Wang L; Cheng Q; Li X
Infect Drug Resist; 2021; 14():3115-3124. PubMed ID: 34413656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
